𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Unnatural Polyketide Analogues Selectively Target the HER Signaling Pathway in Human Breast Cancer Cells

✍ Scribed by Seok Joon Kwon; Moon Il Kim; Bosung Ku; Lydie Coulombel; Jin-Hwan Kim; Joseph H. Shawky; Robert J. Linhardt; Jonathan S. Dordick


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
587 KB
Volume
11
Category
Article
ISSN
1439-4227

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inside Cover: Unnatural Polyketide Analo
✍ Seok Joon Kwon; Moon Il Kim; Bosung Ku; Lydie Coulombel; Jin-Hwan Kim; Joseph H. πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 480 KB

The inside cover picture shows the inhibition of multiple HER receptors by unnatural polyketide analogues synthesized by using in vitro precursor-directed chalcone synthase (CHS) catalysis. For further information on how the inhibition of multiple HER receptors has the potential to improve anticance

Effects of tyrosine kinase inhibitors on
✍ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr

Bisphosphonates suppress insulin-like gr
✍ Xudong Tang; Qunzhou Zhang; Shihong Shi; Yun Yen; Xiangyong Li; Yuefei Zhang; Ke πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 897 KB

## Abstract Adjunctive chemotherapy with bisphosphonates has been reported to delay bone metastasis and improve overall survival in breast cancer. Aside from its antiresorptive effect, bisphosphonates exhibit antitumor activities, __in vitro__ and __in vivo__, __via__ several mechanisms, including

The potent anti-proliferative effect of
✍ Christina MΓΈrk Hansen; Carina Danielsson; Carsten Carlberg πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 458 KB πŸ‘ 1 views

The hormone I ,25-dihydroxyvitamin D3 (VD) has a potential use as an anti-tumor agent, but its clinical applications are restricted by its strong calcemic activity. This has led to the development of VD analogues with selectively increased growthinhibitory activity. One of the most potent analogues